Tscan Therapeutics Inc
(TCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -13,658 | N/A | N/A |
| Depreciation Amortization | 519 | N/A | N/A |
| Accounts payable and accrued liabilities | 161 | N/A | N/A |
| Other Working Capital | 299 | N/A | N/A |
| Other Operating Activity | 157 | 0 | 0 |
| Operating Cash Flow | $-12,522 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,247 | N/A | N/A |
| Investing Cash Flow | $-1,247 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 5 | N/A | N/A |
| Other Financing Activity | 34,807 | 0 | 0 |
| Financing Cash Flow | $34,812 | $N/A | $N/A |
| Beginning Cash Position | 21,316 | N/A | N/A |
| End Cash Position | 42,359 | N/A | N/A |
| Net Cash Flow | $21,043 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -12,522 | N/A | N/A |
| Capital Expenditure | -1,247 | N/A | N/A |
| Free Cash Flow | -13,769 | 0 | 0 |